FINANCIALS

SABSW Sab Biotherapeutics Inc 1833214

Income Statement
Revenue	sabs-20240930	1,207,712
Net Income	sabs-20240930	-10,349,410
Profit Margin		-856.94%

Balance Sheet
Current Assets	32,537,040
Assets	53,797,183
Current Liabilities	8,816,174
Liabilities	16,894,566
Equity	36,902,617

Cash Flow Statement
Operating Cash Flow	-24,759,821
Investing Cash Flow	-21,293,033

Market Analysis
Market Cap	25,426,645
Price	0.11
BVPS	66.40
PS	5.26
FCF	-46,052,854

Dividends

Earnings

Find a discrepancy? The most accurate way to find company fundamental data is to view SABSW documents filed with the SEC.

SABSW Filings Clear

View A List of Tickers